Literature DB >> 18239367

[Liposomal boron delivery system for neutron capture therapy].

Hiroyuki Nakamura1.   

Abstract

Boron neutron capture therapy (BNCT) is a binary cancer treatment based on the nuclear reaction of two essentially nontoxic species, (10)B and thermal neutrons. High accumulation and selective delivery of boron into tumor tissue are the most important requirements to achieve efficient neutron capture therapy of cancers. This review focuses on the liposomal boron delivery system (BDS) as a recent promising approach that meets these requirements for BNCT. BDS involves two strategies: (1) encapsulation of boron in the aqueous core of liposomes and (2) accumulation of boron in the liposomal bilayer. Various boronated liposomes have been developed and significant boron accumulation into tumor tissue with high tumor/blood boron ratios has been achieved by BDS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18239367     DOI: 10.1248/yakushi.128.193

Source DB:  PubMed          Journal:  Yakugaku Zasshi        ISSN: 0031-6903            Impact factor:   0.302


  1 in total

1.  A Novel Boron Lipid to Modify Liposomal Surfaces for Boron Neutron Capture Therapy.

Authors:  Makoto Shirakawa; Alexander Zaboronok; Kei Nakai; Yuhki Sato; Sho Kayaki; Tomonori Sakai; Takao Tsurubuchi; Fumiyo Yoshida; Takashi Nishiyama; Minoru Suzuki; Hisao Tomida; Akira Matsumura
Journal:  Cells       Date:  2021-12-05       Impact factor: 6.600

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.